Related Experiment Video

Updated: Jul 19, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?

V Persy1, M De Broe, M Ketteler

  • 1Department of Pathophysiology, University of Antwerp, Antwerp, Belgium. veerle.persy@ua.ac.be

Kidney International
|October 20, 2006
PubMed

Insights

Ibandronate, a bisphosphonate, reduced vascular calcification in rats with chronic kidney disease. This suggests a link between bone health and blood vessel calcification in kidney failure, offering new treatment possibilities.

Area of Science:

  • Nephrology
  • Endocrinology
  • Vascular Biology

Background:

  • Bisphosphonates are established bone resorption inhibitors, commonly prescribed for osteoporosis.
  • Vascular calcification is a significant complication in chronic kidney disease (CKD).
  • The relationship between bone remodeling and vascular calcification in CKD is an area of active research.

Purpose of the Study:

  • To investigate the effect of ibandronate on uremia-related vascular calcification in a rat model.
  • To explore the potential of bisphosphonates in managing vascular complications associated with chronic renal failure.

Main Methods:

  • Rats with experimentally induced uremia were treated with ibandronate.
  • Vascular calcification development was assessed in the treated group compared to controls.
  • Bone resorption markers and vascular histology were likely evaluated (details not provided in abstract).

Main Results:

  • Ibandronate administration significantly suppressed the development of vascular calcification in rats with uremia.
  • The study demonstrated a reduction in calcification markers in ibandronate-treated rats.

Conclusions:

  • Ibandronate shows potential in mitigating vascular calcification in the context of chronic renal failure.
  • These findings highlight a connection between bone remodeling processes and vascular calcification in CKD.
  • This research opens avenues for novel therapeutic strategies targeting vascular complications in kidney disease patients.

More Related Videos

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models09:01

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...